Email this article to a friend
Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs
-
* Corresponding author: Hong Liu-Seifert liu-seifert_hong@lilly.com
BMC Medicine 2005, 3:21 doi:10.1186/1741-7015-3-21